Emera Renews At-The-Market Equity Program

Emera Incorporated (“Emera” or the “Company”) (TSX/NYSE: EMA) announced today that it has renewed its at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$600,000,000 of common shares (the “Common Shares”) from treasury to the public from time to time at varying prices, at the Company's discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the New York Stock Exchange (the “NYSE”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded (collectively, the “Marketplaces”) at the time of sale.

The ATM Program continues to provide Emera with additional financing flexibility should it be required in the future. The volume and timing of distributions under the ATM Program, if any, will be determined at the Company's sole discretion. The Company has entered into an equity distribution agreement dated December 5, 2025 (the “Equity Distribution Agreement”) with BMO Nesbitt Burns Inc., RBC Dominion Securities Inc. and Scotia Capital Inc. as Canadian agents (the "Canadian Agents"), and BMO Capital Markets Corp., RBC Capital Markets, LLC and Scotia Capital (USA) Inc. as U.S. agents (collectively, the “U.S. Agents” and, together with the Canadian Agents, the “Agents”). Distributions of the Common Shares through the ATM Program will be made pursuant to the terms of the Equity Distribution Agreement. The ATM Program will be effective until January 5, 2029 unless terminated prior to such date by the Company or otherwise in accordance with the terms of the Equity Distribution Agreement. Emera intends to use the net proceeds from the ATM Program, if any, for general corporate purposes.

In connection with the renewal of the ATM Program, the Company has filed: (a) a prospectus supplement dated December 5, 2025 (the “Prospectus Supplement”) to the Company's Canadian short form base shelf prospectus (the “Shelf Prospectus”) filed today with the securities regulatory authorities in each of the provinces of Canada; and (b) a prospectus supplement dated December 5, 2025 (the “U.S. Prospectus Supplement”) to the Company’s U.S. base prospectus (the “U.S. Base Prospectus”) included in its U.S. registration statement on Form F-10 (the “Registration Statement”) filed today with the U.S. Securities and Exchange Commission.